Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
30/05/2025
Maxim Group: Maintains rating on HCW Biologics (HCWB.US) from buy to buy rating, target price adjusted from $120.00 to $35.00.
Latest
2 m ago
Medici: Chen Jianhuan reduced his holdings by 3.0099 million shares.
3 m ago
Ministry of Industry and Information Technology: From January to April, the value added of China's large-scale electronic information manufacturing industry increased by 11.3% year-on-year.
3 m ago
Yu Yuan Group (00846.HK): Zhou Weide will be appointed as an executive director.
3 m ago
Research: Credit boost to Eurozone economy not enough to offset impact of tariffs.
3 m ago
ST Weidi (603023.SH) has revoked the delisting risk warning. The securities abbreviation has been changed to "Weidi Stock".
See all latest
